3 studies found for:    20154213 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: PEG-L-asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: prednisone;   Drug: thioguanine;   Drug: vincristine sulfate;   Drug: vindesine;   Drug: daunoxome;   Drug: fludarabine;   Radiation: Radiation Therapy
2 Completed Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: prednisone;   Drug: thioguanine;   Drug: vincristine sulfate;   Drug: vindesine;   Radiation: radiation therapy
3 Completed Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: dexamethasone;   Drug: asparaginase;   Drug: Asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin;   Drug: doxorubicin;   Drug: Etoposide;   Drug: Ifosfamide;   Drug: mercaptopurine;   Drug: Methotrexate;   Drug: prednisone;   Drug: thioguanine;   Drug: Vincristine;   Drug: Vindesine

Indicates status has not been verified in more than two years